Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06599736 · ClinicalTrials.gov registry record · NA

A Study of RhinAer Stylus for Treating Chronic Rhinitis

A NA study of Chronic Rhinitis, sponsored by Aerin Medical.

Active
Registry status
NA
Development phase
25
Enrollment target
2
Study locations

NCT06599736: Active NA study of Chronic Rhinitis, sponsored by Aerin Medical.

NCT06599736 is a NA study of Chronic Rhinitis that is active but no longer recruiting, run by Aerin Medical. The registered enrollment target is 25 participants, below the 93-participant average among 6 other Chronic Rhinitis trials with a reported enrollment target (73% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06599736, a NA study of Chronic Rhinitis, is active but no longer recruiting, sponsored by Aerin Medical.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
25 participants
Enrollment target
2
Study locations

Study Summary

Post-market study to continue to evaluate the effectiveness of the RhinAer Stylus for chronic rhinitis and the effect of treatment on inflammatory biomarkers.

Primary Outcome

Change from baseline in expression of type-2 inflammatory cytokine markers in nasal mucus samples at 3 months post-procedure

Conditions Studied

Interventions

  • DEVICE RhinAer Stylus

Study Locations (2)

Colorado

  • Colorado ENT & Allergy - Colorado Springs

Ohio

  • University of Cincinnati - Cincinnati

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2024-10-03
Est. Completion 2026-03
Phase NA
Aerin Medical

14 total trials

What the registry record for NCT06599736 still lists

NCT06599736 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 93-participant average among 6 other Chronic Rhinitis trials with a reported enrollment target (73% lower).

The record links to 1 condition, with Chronic Rhinitis appearing as the primary indexed condition, and to 1 intervention - of which RhinAer Stylus is the first listed.

NCT06599736 reports a single indexed study location in Colorado, Ohio.

Frequently Asked Questions

What is clinical trial NCT06599736 about?

NCT06599736 is a clinical study titled "A Study of RhinAer Stylus for Treating Chronic Rhinitis". Post-market study to continue to evaluate the effectiveness of the RhinAer Stylus for chronic rhinitis and the effect of treatment on inflammatory biomarkers.

What is the current status of trial NCT06599736?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2024-10-03. Estimated completion is 2026-03.

What conditions does trial NCT06599736 study?

This clinical trial studies the following conditions: Chronic Rhinitis.

What interventions are being tested in trial NCT06599736?

The interventions under investigation include: RhinAer Stylus (DEVICE).

Who is sponsoring clinical trial NCT06599736?

This trial is sponsored by Aerin Medical, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06599736 being conducted?

This trial has 2 study locations across Colorado, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Rhinitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06599736, the US trial registry maintained by the National Library of Medicine. NCT06599736 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.